InvestorsHub Logo
Followers 58
Posts 10055
Boards Moderated 1
Alias Born 09/21/2016

Re: dayneyus post# 360345

Saturday, 05/14/2022 3:36:14 PM

Saturday, May 14, 2022 3:36:14 PM

Post# of 458853
IMO, the patent is about diagnostics, analysis and follow on treatment related to testing. Agree it seems likely other treatments (ex. A xxx) might follow a specified variant sequence and defined treatment protocol.

IMO, this is a variation of ..."take 2 of these and call me in a week." . It's about being more precise with subject analysis and corresponding S1R treatments.

They are zeroing in on custom medicine for each subject by applying unspecified analysis and corresponding treatment, but all w/in the S1R MOA envelope.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News